On 16 December 2014, orphan designation (EU/3/14/1384) was granted by the European Commission to Centre National de la Recherche Scientifique (CNRS), France, for ((E)-1-(4'-chlorophenyl)-3-(4-hydroxy-3-metoxyphenyl)prop-2-en-1-one) for the treatment of WHIM syndrome.
|Disease / condition||
Treatment of WHIM syndrome
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.